News
Zacks Investment Research on MSN21h
FDA Grants Accelerated Approval to Regeneron's Blood Cancer DrugRegeneron Pharmaceuticals, Inc. REGN obtained FDA approval for linvoseltamab-gcpt for the treatment of relapsed or refractory ...
Pharmaceutical Technology on MSN23h
Regeneron nabs dosing edge with Lynozyfic’s FDA approval in multiple myeloma"Regeneron nabs dosing edge with Lynozyfic’s FDA approval in multiple myeloma" was originally created and published by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback